Why the study?
Staphylococcus saprophyticus is a coagulase-negative staphylococcus classically associated with uncomplicated urinary tract infections and is rarely implicated in invasive infections such as infective endocarditis.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
This case report demonstrates that Staphylococcus saprophyticus, typically a urinary tract pathogen, can rarely cause infective endocarditis in patients with underlying congenital heart disease and responds to targeted intravenous antimicrobial therapy.
Infective endocarditis (IE) is a serious and potentially fatal condition commonly caused by Staphylococcus aureus, viridans group streptococci, and Enterococcus species. Staphylococcus saprophyticus, a coagulasenegative staphylococcus, is classically associated with uncomplicated urinary tract infections and is rarely implicated in invasive infections. We report a rare case of Staphylococcus saprophyticus infective endocarditis in a 17-year-old female with underlying congenital heart disease. The diagnosis was established based on blood culture isolation and echocardiographic evidence fulfilling the Duke criteria. The patient responded favorably to targeted intravenous antimicrobial therapy. This case highlights the importance of considering uncommon pathogens as potential etiological agents of infective endocarditis, particularly in patients with structural heart disease.
No takes yet. Share an insight, caveat, or question.
Pol et al. (2026) conducted a case report in Staphylococcus saprophyticus infective endocarditis with congenital heart disease (ventricular septal defect) (n=1). Intravenous vancomycin and gentamicin was evaluated on Clinical resolution of infective endocarditis (resolution of fever, reduction in inflammatory markers, and cardiorespiratory stabilization).
Synapse has enriched 10 related papers. Consider them for comparative context: